Skip to main navigation

Linkedin
Twitter
Facebook
Instagram

Company
Pipeline
Partnering
- Partnering & Collaboration
Patients
Careers
- Culture
- Benefits
- Jobs
Investors & Media
Contact
- Contact Us
- Our Offices

Company ►
Pipeline ►
Partnering ►
- Partnering & Collaboration
Patients ►
Careers ►
- Culture
- Benefits
- Jobs
Investors & Media ►
Contact ►
- Contact Us
- Our Offices

IR Banner

Home > Investors > Quarterly Results Quarterly Results

Quarterly Results

Show all

2022

Third Quarter

Lumos Pharma Reports Third Quarter 2022 Financial Results and Clinical Development Updates
Lumos Pharma, Inc. Interim Analysis & Third Quarter 2022 Earnings Conference Call
Form 10-Q

Second Quarter

Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
Lumos Pharma, Inc. Second Quarter 2022 Earnings Conference Call
Form 10-Q

First Quarter

Lumos Pharma Reports First Quarter 2022 Financial Results and Clinical Development Updates
Lumos Pharma, Inc. First Quarter 2022 Earnings Conference Call
Form 10-Q

2021

Fourth Quarter

Lumos Pharma Reports Full Year 2021 Financial Results and Announces Plan to Perform Interim Analyses of OraGrowtH Trials
Lumos Pharma, Inc. Fourth Quarter 2021 Earnings Conference Call
Form 10-K

Third Quarter

Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates
Lumos Pharma, Inc. Third Quarter 2021 Earnings Conference Call
Form 10-Q

Second Quarter

Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
Lumos Pharma, Inc. Second Quarter 2021 Earnings Conference Call
Form 10-Q

First Quarter

Lumos Pharma to Report First Quarter 2021 Financial Results and Host Conference Call on May 5, 2021
Lumos Pharma, Inc. First Quarter 2021 Earnings Conference Call
Form 10-Q

2020

Fourth Quarter

Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
Lumos Pharma, Inc. Fourth Quarter 2020 Earnings Conference Call
Form 10-K

Third Quarter

Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
Lumos Pharma, Inc. Third Quarter 2020 Earnings Conference Call
Form 10-Q

Second Quarter

Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
Lumos Pharma, Inc. Second Quarter 2020 Earnings Conference Call
Form 10-Q

First Quarter

Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
Lumos Pharma, Inc. First Quarter 2020 Earnings Conference Call
Form 10-Q

Email Alerts Subscription

Download Library

Search Investors

Facebook
LinkedIn
Twitter

Stay Connected

Receive updates on the latest news from Lumos Pharma.

Email

Linkedin
Twitter
Facebook

Company
Pipeline
Partnering
- Partnering & Collaboration
Patients
Careers
- Culture
- Benefits
- Jobs
Investors & Media
Contact
- Contact Us
- Our Offices

Privacy Policy
Compassionate Use Policy
Terms of Use
© 2022 Lumos Pharma
Site By CreativePickle